Other Information.
−Removed: Executive Employment Agreement, dated November 8, 2021, by and between the Company and Robert Hoffman (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on November 12, 2021).
−Removed: Second Amended Employment Agreement, dated November 8, 2021, by and between the Company and Saiid Zarrabian (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on November 12, 2021).
+Added: Bylaws of the Company, as amended*
+Added: Form of Warrant Certificate (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the SEC on April 13, 2022)
+Added: Form of Placement Agent Warrant Certificate (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed with the SEC on April 13, 2022)
+Added: Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on April 13, 2022)
+Added: Placement Agency Agreement (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the SEC on April 13, 2022)
Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
2 unchanged sentences
Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
−Removed: Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document*
+Added: Inline XBRL Instance Document –
+Added: the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document*
Inline XBRL Taxonomy Extension Schema Document*
5 unchanged sentences
* Filed herewith
−Removed: The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.
+Added: ** The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed”
+Added: for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Kintara Therapeutics, Inc.
−Removed: February 11, 2022
/s/ Robert E.
1 unchanged sentence
(Principal Executive Officer)
−Removed: February 11, 2022
/s/ Scott Praill
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.